Real-World Activity and Safety of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients with Refractory Metastatic Colorectal Cancer.
Arrichiello G, Perrone A, Napolitano S, Martini G, De Falco V, Incoronato P, Laterza MM, Facchini G, Famiglietti V, Nacca V, Paragliola F, Napolitano R, Suarato G, Nicastro A, Martinelli E, Ciardiello D, Ciardiello F, Troiani T.
Arrichiello G, et al. Among authors: troiani t.
Target Oncol. 2022 Nov;17(6):635-642. doi: 10.1007/s11523-022-00916-8. Epub 2022 Oct 14.
Target Oncol. 2022.
PMID: 36239883
Free PMC article.